Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: The PREseAP study;Ensayo clínico aleatorizado para evaluar la eficacia de un programa integral de prevención secundaria de las enfermedades cardiovasculares en atención primaria: estudio PREseAP

Revista Espanola de Cardiologia

Volumn 64, Issue 1, 2011, Pages 13-20

  Brotons, Carlos ^a   Soriano, Núria ^a   Moral, Irene ^a   Rodrigo, María P ^b   Kloppe, Pilar ^c   Rodríguez, Ana I ^d   González, María L ^e   Ariño, Dolores ^f   Orozco, Domingo ^g   Buitrago, Francisco ^h   Pepió, Josep M ⁱ   Borrás, Isabel ^j  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b Centro de Salud Plaza Del Ejército ^*  (Spain)

^c Centro de Salud Las Calesas   (Spain)

^d Las Arenas Getxo   (Spain)

^e Centro de Salud San Agustin   (Spain)

^f Aragon Health Service   (Spain)

^g San Juan Hospital   (Spain)

^h Centro de Salud La Paz   (Spain)

ⁱ Centro de Salud Reus 1   (Spain)

^j Centro de Salud Manacor   (Spain)

more..

Author keywords

Cardiovascular disease; General practice; Secondary prevention

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLUSTER ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH CENTER; HEALTH PROGRAM; HOSPITAL READMISSION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; SPAIN; STROKE; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SECONDARY PREVENTION;

EID: 78651289884     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.07.005     Document Type: Article

References (18)

1. A.J.B. Brady, M.A. Oliver, and J.B. Pittard Secondary prevention in 24431 patients with coronary heart disease: survey in primary care BMJ. 322 2001 1463
2. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, and R. Cifkova European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur Heart J. 28 2007 2375 2414 (Pubitemid 47542237)
3. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörä lä, U. Keil EUROASPIRE I and II Group Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries Lancet. 357 2001 995 1001
4. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554-72.
5. K. Kotseva, D. Wood, G. De Backer, D. De Backer, K. Pyörä lä, U. Keil for the EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet. 373 2009 929 940
6. C. Brotons, G. Permanyer, I. Moral, A. Ribera, P. Cascant, J. Pinar en nombre del Grupo de Investigación del estudio PREMISE Prevención secundaria del infarto de miocardio y calidad de vida relacionada con la salud Med Clin (Barc). 119 2002 9 12
7. A.W. Murphy, M.E. Cupples, S.M. Smith, M. Byrne, M.C. Byrne, and J. Newell Effect of tailored practice and patient care plan son secondary prevention of heart disease in general practice: cluster randomised controlled trial BMJ. 339 2009 b4220
8. J.A. Velasco, J. Cosín, M. De Oya, and E. De Teresa Programa de intervención para mejorar la prevención secundaria del infarto agudo de miocardio. Resultados del estudio PRESENTE (Prevención secundaria temprana) Rev Esp Cardiol. 57 2004 146 154
9. M.A. Muñoz, I. Subirana, R. Ramos, A. Franz, J. Vila, J. Marrugat por los investigadores del studio ICAR Eficacia de un programa intensivo de prevención secundaria de la cardiopatía isquémica tras 5 años de intervención Med Clin (Barc). 130 2008 521 525
10. M.A. Muñoz, J. Vila, M. Cabañero, C. Rebato, I. Subirana, and J. Sala Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial Int J Cardiol. 118 2007 312 320
11. D. Orozco-Beltrán, C. Brotons, I. Moral, N. Soriano, M.A. Del Valle, and A.I. Rodríguez Factores determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular: estudio PREseAP Rev Esp Cardiol. 61 2008 317 321
12. C. Brotons, D. Ariño, I. Borrás, F. Buitrago, M.L. González, and P. Kloppe Evaluación de la eficacia de un programa integral de prevención secundaria de las enfermedades cardiovasculares en atención primaria: estudio PREseAP Aten Primaria. 37 2006 295 298
13. D. Goldberg, K. Bridges, P. Duncan-Jones, and D. Grayson Detecting anxiety and depression in general medical settings BMJ. 97 1988 897 899
14. C. Montón, M.J. Pérez-Echevarría, R. Campos, J. García, and A. Lobo Escalas de ansiedad y depresión de Goldberg: una guía de entrevista eficaz para la detección del malestar psíquico Aten Primaria. 12 1993 345 349
15. N.C. Campbell, L.D. Ritchie, J. Thain, H. Deans, J. Rawles, and J. Squair Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care Heart. 80 1998 447 452 (Pubitemid 28535530)
16. P. Murchie, N.C. Campbell, L.D. Ritchie, J.A. Simpson, and J. Thain Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care BMJ. 326 2002 84 87
17. H. Cohen, G. Gibson, and M.H. Alderman Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents Am J Med. 108 2000 2 8
18. J. Hippisley-Cox, M. Pringle, V. Hammersley, N. Crown, A. Wynn, and A. Meal Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care BMJ. 323 2001 666 669